Michael David Smith - Senior VP, Development at KalVista Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Senior VP, Development
Stock Symbol
KALV on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Michael David Smith since 10/9/2024

Holdings reported by Michael David Smith for KalVista Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 15.5K $127K $8.23 May 17, 2022 Direct Common Stock
Employee Stock Option (Right to Buy) 10.3K May 17, 2022 Direct Common Stock
Common Stock 0 $12.44 Jun 1, 2021 Direct

Transactions reported by Michael David Smith for KalVista Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.